Jolien Janssen

Jolien Janssen  
MD PhD student / trainee GP

Education
Medicine, Utrecht University

Research focus
Cognitive impairment in type 2 diabetes

Current projects
Jolien Janssen is involved in the CAROLINA and CARMELINA trials since 2013. These two large randomized controlled trials evaluate the effect of treatment with the glucose lowering agent linagliptin on cardiovascular outcomes in people with diabetes type 2. Cognitive assessment is an integral part of these trials, and longitudinal cognitive data have been collected from over 7000 patients. The cognition part of these studies aims to establish if treatment with linagliptin can reduce the occurrence of accelerated cognitive decline in patients with type 2 diabetes mellitus. Chloë Verhagen is now the primary contact for these studies since Jolien is currently working as a trainee GP.

Studies
CAROLINA cognition I
CARMELINA cognition I

Contact
E: j.janssen-5@umcutrecht.nl

Publications
Web link to PubMed [https://www.ncbi.nlm.nih.gov/pubmed/?term=Janssen+J%5BAuthor%5D+cognitive+diabetes]